openPR Logo
Press release

Proteros announces the appointment of Dr. Klaus Hinterding as Chief Scientific Officer and member of the management board

02-10-2012 06:46 AM CET | Health & Medicine

Press release from: Proteros biostructures GmbH

Martinsried, Germany, February 9, 2012. Proteros biostructures GmbH (Proteros) announced today that Dr. Klaus Hinterding, formerly at Hoffmann-La Roche Ltd. (Roche), has joined the company as Chief Scientific Officer and member of the management board. Dr. Hinterding brings to Proteros considerable pharmaceutical industry experience that spans early research through to clinical development in various therapeutic areas.

At Novartis, his research contributed to the understanding of the mode-of-action of GilenyaTM, licensed for the treatment of multiple sclerosis, and he led the team that discovered a selective S1P-receptor agonist, currently in Phase II for the same indication. As Life Cycle Leader at Roche he implemented an innovative development and commercial strategy for one of Roche´s leading late-stage development candidates that culminated in a multi-thousand patient clinical program in cardiovascular disease. Dr. Hinterding has led various international research & development collaborations and is an author and inventor of more than 20 patents and publications. He was a post-doctoral fellow at Harvard University and received his PhD in organic Chemistry from the University of Karlsruhe.

Torsten Neuefeind, founder and CEO of Proteros, said: “Klaus’ significant background in medicinal chemistry, drug discovery and clinical development will have an immediate impact on Proteros’ growing integrated lead discovery business. Klaus will be responsible for growing the organization that supports our clients as they rely on Proteros to deliver analytical services of crystallography, compound profiling, proteins and increasingly lead compounds, through innovative, integrated structure guided drug discovery collaborations. We welcome Klaus to Proteros.”

About Proteros biostructures GmbH:

Proteros is a privately held company that provides services and proprietary technologies to support integrated drug discovery. Proteros uses its technical expertise, industrial processes and unique technologies for crystallography, kinetic and thermodynamic profiling and fragment-based lead generation incorporating protein structure inspired compound and fragment libraries. The platform enables ‘knowledge driven lead engineering’ to accelerate and improve protein structure analysis and structure-based drug discovery. Proteros complements its clients’ internal capabilities with external expertise and access to flexible resources. Proteros currently provides services to more than 80 pharmaceutical and biotechnology clients in North America, Europe and Asia. Proteros US, Inc. is a wholly owned subsidiary of Proteros established to serve the growing customer base in North America.

For further information please visit the website at:

Proteros biostructures GmbH
Thomas Waldmann, Ph.D.
Bunsenstrasse 7a
D-82152, Martinsried
Phone: +49 89 7007 61 – 0

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Proteros announces the appointment of Dr. Klaus Hinterding as Chief Scientific Officer and member of the management board here

News-ID: 210335 • Views: 2202

More Releases from Proteros biostructures GmbH

Largest-ever Financing allows for Expansion of Drug Discovery Capabilities MARTINSRIED, GERMANY (August 6th, 2012) – Proteros biostructures GmbH (‘Proteros’) announced today that it had successfully closed a financing round of five million Euros to fund the continued expansion and growth of the company. The financing round was led by BayBG, a key equity investor for Proteros. The financing round is the third and largest investment into the firm since the inception
Proteros and Eisai Co., Ltd enter into Integrated Lead Discovery Collaboration
Martinsried (Germany), April 16, 2012. Proteros biostructures GmbH today announced that the company has entered into a research collaboration with Eisai Co., Ltd (Japan) to identify small molecule inhibitors against a target selected by Eisai in the field of immunology. Under the agreement Proteros will deliver a novel lead compound applying its integrated lead discovery platform that includes X-Ray structural biology, biophysical screening and profiling, novel fragment libraries and medicinal chemistry
Janssen Pharmaceutica NV and Proteros expand relationship and enter into Global …
Martinsried Jan 09, 2012. Janssen Research & Development, a division of Janssen Pharmaceutica NV (“Janssen”) and Proteros biostructures GmbH (“Proteros”) today announced they have entered into a long-term global service agreement granting Janssen privileged access to Proteros portfolio of discovery technologies and services. Under the agreement Janssen will have broad access to Proteros’ drug discovery technologies, including structural biology, biophysical screening and profiling service, novel fragment libraries, medicinal chemistry expertise and
Proteros has relocated to a tailor-made facility in Martinsried
Martinsried, October 24th 2011. Proteros biostructures GmbH is further extending its business capacities by moving into a new building in Munich-Martinsried, one of the leading Biotech locations in Germany. After a two-year planning period, Proteros has reached an important milestone in its development by centralizing all operations within a purpose-built facility. The 4,000 square-meter of laboratory and office space, worth a total of about 15 M €, has been optimally designed

All 5 Releases

More Releases for Klaus

Global Railway Power Cables Market Forecast 2018-2025 Glenair, Belden, Tecnikabe …
Market study on Global Railway Power Cables 2018 Research Report presents a professional and complete analysis of Global Railway Power Cables Market on the current market situation. Report provides a general overview of the Railway Power Cables industry 2018 including definitions, classifications, Railway Power Cables market analysis, a wide range of applications and Railway Power Cables industry chain structure. The 2018's report on Railway Power Cables industry offers the global
Global Railway Power Cables Market 2018 - Klaus Faber, Glenair, L&T Metro Rail L …
Apex Market Reports, recently published a detailed market research study focused on the “Railway Power Cables Market” across the global, regional and country level. The report provides 360° analysis of “Railway Power Cables Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Railway
Global Magnetic Drive Pumps Market 2017 : Flowserve, Verder, Klaus Union, Dickow …
Top Manufacture Analysis Of Magnetic Drive Pumps Market 2017 Includes Market outline, section by Application, Market by Region and Production, Revenue (Value), worth Trend by kind. The Markets And analysis study delivers necessary information and realistic data of the globe Magnetic Drive Pumps market. The report presents a deep study of the market growth factors and drivers. In-depth analysis of the Magnetic Drive Pumps Market limitations and thus the opportunities
Klaus von Hippel, the new Product Manager of „Checkweighing Systems“ at Bize …
Balingen, 30th August 2011 - Klaus von Hippel assumed his duties as the new Product Manager of "Checkweighing Systems" at Bizerba on 01 August 2011. Before von Hippel (42) came on board at Bizerba , he worked in product management for Ishida, an international provider of weighing and packaging solutions. Prior to that he worked for over ten years in various international sales positions for OCS-Checkweighers. "We at Bizerba extend a
04-10-2008 | Science & Education
Klaus Oestreicher Lectures at the Wiesbaden International Summer University
The University of Applied Studies Wiesbaden organises the Wiesbaden International Summer University for international students in July/August 2008. Especially students from the USA and Eastern Europe are in the university’s focus. In the globalisation process, international exchange is gaining in importance. To make this internationalisation more effective, the University of Applied Studies Wiesbaden invites foreign students to the Wiesbaden International Summer University WISU, which is directed by Prof. Dr.
Klaus Fenchel joins DITA Committee
Berlin, 10th January 2006 - Klaus Fenchel, managing director at Ovidius, Berlin, has recently joined the DITA Machine Industry Sub-Committee. DITA is a topic-oriented approach to XML-based documentation and is becoming widely-adopted. As a member of the committee Klaus Fenchel will actively participate in developing DITA design principles for the machine industry and contribute with his expert knowledge and experience in content creation and management to the committees' work. DITA (Darwin